Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy

Follmer C.

Expert Rev Neurother. 2014 Jun;14(6):703-16. doi: 10.1586/14737175.2014.920235.

Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side?

Schirinzi T, Chiaravalloti A, Davoli A, Pierantozzi M, Sancesario G.

Neurol Sci. 2014 Dec;35(12):2013-5. doi: 10.1007/s10072-014-1836-z. Epub 2014 May 23.

Targeted discovery and validation of plasma biomarkers of Parkinson's disease

Pan C, Zhou Y, Dator R, Ginghina C, Zhao Y, Movius J, Peskind E, Zabetian CP, Quinn J, Galasko D, Stewart T, Shi M, Zhang J.

J Proteome Res. 2014 Nov 7;13(11):4535-45. doi: 10.1021/pr500421v. Epub 2014 Jun 11.

Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease

Ambrosi G, Ghezzi C, Sepe S, Milanese C, Payan-Gomez C, Bombardieri CR, Armentero MT, Zangaglia R, Pacchetti C, Mastroberardino PG, Blandini F.

Biochim Biophys Acta. 2014 Sep;1842(9):1385-94. doi: 10.1016/j.bbadis.2014.05.008. Epub 2014 May 20.

Emerging therapies for Parkinson's disease: from bench to bedside

Tarazi FI, Sahli ZT, Wolny M, Mousa SA.

Pharmacol Ther. 2014 Nov;144(2):123-33. doi: 10.1016/j.pharmthera.2014.05.010. Epub 2014 May 20.

Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases

Lee EH, Seo SR.

BMB Rep. 2014 Jul;47(7):369-75. doi: 10.5483/bmbrep.2014.47.7.086.

Delayed intracranial hemorrhage after deep brain stimulation in two Parkinson's disease patients

Chung EJ, Kim MS, Kim SJ.

J Neurol Sci. 2014 Jul 15;342(1-2):202-3. doi: 10.1016/j.jns.2014.05.008. Epub 2014 May 15.

Circulating miRNAs as biomarkers for neurodegenerative disorders

Grasso M, Piscopo P, Confaloni A, Denti MA.

Molecules. 2014 May 23;19(5):6891-910. doi: 10.3390/molecules19056891.

Sleep/wake problems in Parkinson's disease: pathophysiology and clinicopathologic correlations

Ondo WG.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S3-13. doi: 10.1007/s00702-014-1239-6. Epub 2014 May 25.

Prions and prion-like proteins

Fraser PE.

J Biol Chem. 2014 Jul 18;289(29):19839-40. doi: 10.1074/jbc.R114.583492. Epub 2014 May 23.

Prions: generation and spread versus neurotoxicity

Halliday M, Radford H, Mallucci GR.

J Biol Chem. 2014 Jul 18;289(29):19862-8. doi: 10.1074/jbc.R114.568477. Epub 2014 May 23.

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro S, Eckermann K, Outeiro TF.

Front Mol Neurosci. 2014 May 13;7:42. doi: 10.3389/fnmol.2014.00042. eCollection 2014.

Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease

Benazzouz A, Mamad O, Abedi P, Bouali-Benazzouz R, Chetrit J.

Front Aging Neurosci. 2014 May 13;6:87. doi: 10.3389/fnagi.2014.00087. eCollection 2014.

[Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease]

Santos-Garcia D, de Deus T, Lopez-Pazos E, Macias-Arribi M, Llaneza-Gonzalez MA, Echarri-Piudo A, Carpintero P, de la Fuente-Fernandez R.

Rev Neurol. 2014 Jun 1;58(11):505-15.

Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients

Brusa L, Musco S, Bernardi G, Iani C, Pierantozzi M, Stanzione P, Stefani A, Finazzi Agro' E.

Parkinsonism Relat Disord. 2014 Aug;20(8):931-2. doi: 10.1016/j.parkreldis.2014.04.020. Epub 2014 Apr 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias